Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This study seeks to evaluate the efficacy of a contingency management (CM) intervention
compared to a yoked control condition for eliminating illicit stimulant use and for
decreasing time to initiating post exposure prophylaxis (PEP), for improving adherence to
PEP, and for completing PEP following a potential HIV-exposure event. Men who have sex with
men who use cocaine amphetamine or methamphetamine frequently also have high risk sexual
behaviors during or after their drug use. The objective of this study evaluates whether the
use of CM that targets stimulant use significantly aids men who have sex with men who use
stimulants and also engage in high-risk sexual transmission behaviors to be able to initiate,
adhere to and complete PEP, thereby optimizing the utility of a biomedical HIV prevention
intervention for reducing HIV incidence in this very high-risk group of MSM.
Phase:
Phase 2
Details
Lead Sponsor:
Friends Research Institute, Inc.
Collaborator:
University of California, Los Angeles
Treatments:
Central Nervous System Stimulants Emtricitabine Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Tenofovir